肿瘤相关巨噬细胞的表观遗传景观:在肿瘤微环境中协调免疫逃避。

IF 10.1 1区 医学 Q1 ONCOLOGY
Xiaodie Liu , Hongqi Li , Ming Yuan , Jipeng Wan , Jianbin Guo , Xiaoyu Dong , Xueyang Jin , Chunrun Yang , Guoyun Wang
{"title":"肿瘤相关巨噬细胞的表观遗传景观:在肿瘤微环境中协调免疫逃避。","authors":"Xiaodie Liu ,&nbsp;Hongqi Li ,&nbsp;Ming Yuan ,&nbsp;Jipeng Wan ,&nbsp;Jianbin Guo ,&nbsp;Xiaoyu Dong ,&nbsp;Xueyang Jin ,&nbsp;Chunrun Yang ,&nbsp;Guoyun Wang","doi":"10.1016/j.canlet.2025.217972","DOIUrl":null,"url":null,"abstract":"<div><div>Tumor-associated macrophages (TAMs), the predominant immune cell population within the tumor immune microenvironment (TIME), play a vital role in promoting immune evasion and driving tumor progression. Beyond their well-established roles in reprogramming oncogenic signaling and silencing tumor suppressors, emerging evidence highlights that epigenetic modifications also critically shape the immunogenic landscape of tumors by modulating the phenotype and function of infiltrating immune cells. The TIME imposes persistent metabolic and inflammatory stressors—such as hypoxia, nutrient deprivation, and lactate accumulation—that profoundly influence the epigenetic and transcriptional states of TAMs, promoting their phenotypic plasticity and skewing them toward immunosuppressive, pro-tumoral phenotypes. Notably, this dynamic and reversible reprogramming closely parallels the defining features of epigenetic regulation, which is inherently sensitive to environmental stimuli and governs cellular identity. In this review, we comprehensively examine how extracellular cues within the TME rewire the expression and activity of key epigenetic regulators in TAMs, activate downstream signaling pathways, and reshape their molecular functions to reinforce tumor-supportive programs. Deciphering these epigenetic circuits provides a framework for therapeutic strategies aimed at re-educating TAMs toward anti-tumor phenotypes and enhancing the efficacy of immunotherapies.</div></div>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":"632 ","pages":"Article 217972"},"PeriodicalIF":10.1000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The epigenetic landscape of tumor-associated macrophages: orchestrating immune evasion in the tumor microenvironment\",\"authors\":\"Xiaodie Liu ,&nbsp;Hongqi Li ,&nbsp;Ming Yuan ,&nbsp;Jipeng Wan ,&nbsp;Jianbin Guo ,&nbsp;Xiaoyu Dong ,&nbsp;Xueyang Jin ,&nbsp;Chunrun Yang ,&nbsp;Guoyun Wang\",\"doi\":\"10.1016/j.canlet.2025.217972\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Tumor-associated macrophages (TAMs), the predominant immune cell population within the tumor immune microenvironment (TIME), play a vital role in promoting immune evasion and driving tumor progression. Beyond their well-established roles in reprogramming oncogenic signaling and silencing tumor suppressors, emerging evidence highlights that epigenetic modifications also critically shape the immunogenic landscape of tumors by modulating the phenotype and function of infiltrating immune cells. The TIME imposes persistent metabolic and inflammatory stressors—such as hypoxia, nutrient deprivation, and lactate accumulation—that profoundly influence the epigenetic and transcriptional states of TAMs, promoting their phenotypic plasticity and skewing them toward immunosuppressive, pro-tumoral phenotypes. Notably, this dynamic and reversible reprogramming closely parallels the defining features of epigenetic regulation, which is inherently sensitive to environmental stimuli and governs cellular identity. In this review, we comprehensively examine how extracellular cues within the TME rewire the expression and activity of key epigenetic regulators in TAMs, activate downstream signaling pathways, and reshape their molecular functions to reinforce tumor-supportive programs. Deciphering these epigenetic circuits provides a framework for therapeutic strategies aimed at re-educating TAMs toward anti-tumor phenotypes and enhancing the efficacy of immunotherapies.</div></div>\",\"PeriodicalId\":9506,\"journal\":{\"name\":\"Cancer letters\",\"volume\":\"632 \",\"pages\":\"Article 217972\"},\"PeriodicalIF\":10.1000,\"publicationDate\":\"2025-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0304383525005415\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304383525005415","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

肿瘤相关巨噬细胞(tumor -associated macrophages, tam)是肿瘤免疫微环境(tumor immune microenvironment, TIME)中的主要免疫细胞群,在促进免疫逃避和驱动肿瘤进展中起着至关重要的作用。除了它们在致癌信号重编程和肿瘤抑制基因沉默中的作用外,新出现的证据强调,表观遗传修饰还通过调节浸润性免疫细胞的表型和功能,关键地塑造肿瘤的免疫原性景观。时间施加持续的代谢和炎症应激因子,如缺氧、营养剥夺和乳酸积累,深刻影响tam的表观遗传和转录状态,促进其表型可塑性,并使其向免疫抑制、促肿瘤表型倾斜。值得注意的是,这种动态和可逆的重编程与表观遗传调控的定义特征密切相关,表观遗传调控天生对环境刺激敏感,并控制细胞身份。在这篇综述中,我们全面研究了TME中的细胞外信号如何重新连接TME中关键表观遗传调控因子的表达和活性,激活下游信号通路,并重塑其分子功能以加强肿瘤支持程序。破译这些表观遗传回路为旨在重新教育tam抗肿瘤表型和增强免疫治疗效果的治疗策略提供了框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The epigenetic landscape of tumor-associated macrophages: orchestrating immune evasion in the tumor microenvironment
Tumor-associated macrophages (TAMs), the predominant immune cell population within the tumor immune microenvironment (TIME), play a vital role in promoting immune evasion and driving tumor progression. Beyond their well-established roles in reprogramming oncogenic signaling and silencing tumor suppressors, emerging evidence highlights that epigenetic modifications also critically shape the immunogenic landscape of tumors by modulating the phenotype and function of infiltrating immune cells. The TIME imposes persistent metabolic and inflammatory stressors—such as hypoxia, nutrient deprivation, and lactate accumulation—that profoundly influence the epigenetic and transcriptional states of TAMs, promoting their phenotypic plasticity and skewing them toward immunosuppressive, pro-tumoral phenotypes. Notably, this dynamic and reversible reprogramming closely parallels the defining features of epigenetic regulation, which is inherently sensitive to environmental stimuli and governs cellular identity. In this review, we comprehensively examine how extracellular cues within the TME rewire the expression and activity of key epigenetic regulators in TAMs, activate downstream signaling pathways, and reshape their molecular functions to reinforce tumor-supportive programs. Deciphering these epigenetic circuits provides a framework for therapeutic strategies aimed at re-educating TAMs toward anti-tumor phenotypes and enhancing the efficacy of immunotherapies.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer letters
Cancer letters 医学-肿瘤学
CiteScore
17.70
自引率
2.10%
发文量
427
审稿时长
15 days
期刊介绍: Cancer Letters is a reputable international journal that serves as a platform for significant and original contributions in cancer research. The journal welcomes both full-length articles and Mini Reviews in the wide-ranging field of basic and translational oncology. Furthermore, it frequently presents Special Issues that shed light on current and topical areas in cancer research. Cancer Letters is highly interested in various fundamental aspects that can cater to a diverse readership. These areas include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal actively focuses on experimental therapeutics, particularly the advancement of targeted therapies for personalized cancer medicine, such as metronomic chemotherapy. By publishing groundbreaking research and promoting advancements in cancer treatments, Cancer Letters aims to actively contribute to the fight against cancer and the improvement of patient outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信